Renaissance Technologies
KPRX icon

Renaissance Technologies’s Kiora Pharmaceuticals KPRX Stock Holding History

Renaissance Technologies’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.4K Buy
+29,824
New +$74.9K ﹤0.01% 3006
2026
Q1 		– Sell
-21,200
Closed -$41.8K – 3493
2025
Q4 		$41.8K Buy
21,200
+8,800
+71% +$20.1K ﹤0.01% 3100
2025
Q3 		$34.5K Buy
+12,400
New +$34.1K ﹤0.01% 3388
2024
Q2 		– Sell
-1,851
Closed -$12K – 3759
2024
Q1 		$12K Sell
1,851
-227
-11% -$1.27K ﹤0.01% 3619
2023
Q4 		$10K Buy
+2,078
New +$10.8K ﹤0.01% 3642
2022
Q3 		– Sell
-116
Closed -$20K – 4248
2022
Q2 		$20K Sell
116
-144
-55% -$24.1K ﹤0.01% 4118
2022
Q1 		$58K Buy
+260
New +$68K ﹤0.01% 3887
2021
Q3 		– Sell
-251
Closed -$328K – 3663
2021
Q2 		$328K Sell
251
-156
-38% -$242K ﹤0.01% 3118
2021
Q1 		$730K Buy
+407
New +$887K ﹤0.01% 2750
2020
Q3 		– Sell
-154
Closed -$267K – 3530
2020
Q2 		$267K Buy
154
+1
+0.7% +$1.88K ﹤0.01% 3081
2020
Q1 		$287K Buy
153
+62
+68% +$133K ﹤0.01% 2995
2019
Q4 		$329K Buy
+91
New +$177K ﹤0.01% 3046

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies's KPRX Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 29,824 shares worth $78.4K. The stake represents ﹤0.01% of the portfolio and ranks #3006 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in KPRX as recently as Q4 2025.

Renaissance Technologies first reported a position in KPRX in Q4 2019 and has held it in 12 quarters since. The position peaked at $730K in Q1 2021. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Renaissance Technologies held 29,824 shares of Kiora Pharmaceuticals worth $78.4K as of Q2 2026.
  • Kiora Pharmaceuticals was a new Renaissance Technologies position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3006 holding.
  • Renaissance Technologies first reported a position in Kiora Pharmaceuticals in Q4 2019 and has held it in 12 quarters since.
  • Renaissance Technologies's Kiora Pharmaceuticals position peaked at $730K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.